Identification | |
---|---|
Name | 3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol |
Accession Number | DB07969 |
Type | small molecule |
Description | Not Available |
Structure |
|
Categories (*) | |
Molecular Weight | 388.3863 |
Groups | experimental |
Monoisotopic Weight | 388.151095865 |
Pharmacology | |
Indication | Not Available |
Mechanism of action | Not Available |
Absorption | Not Available |
Protein binding | Not Available |
Biotransformation | Not Available |
Route of elimination | Not Available |
Toxicity | Not Available |
Affected organisms | Not Available |
Interactions | |
Drug Interactions | Not Available |
Food Interactions | Not Available |
Hepatocyte growth factor receptor | |
---|---|
Name | Hepatocyte growth factor receptor |
Gene Name | MET |
Pharmacological action | unknown |
Actions | Not Available |
References |
|
DTHybrid score | 1.74 |
Id | Partner name | Gene Name | Score |
---|---|---|---|
990 | Dual specificity mitogen-activated protein kinase kinase 1 | MAP2K1 | 0.0869 |
4177 | Proto-oncogene tyrosine-protein kinase receptor ret | RET | 0.0357 |
407 | Vascular endothelial growth factor receptor 2 | KDR | 0.0289 |
4757 | Cytochrome P450 2C9 | CYP2C9 | 0.0125 |
4512 | Cytochrome P450 3A4 | CYP3A4 | 0.0111 |